Melodiol Global Health (COPHF) Stock Price, News & Analysis

Company Overview

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Key Stats

• Today's Range: $0.12 to $0.12
• 50-Day Range: $0.12 to $0.12
• 52-Week Range: $0.00 to $9.47
• Volume: N/A
• Average Volume: 451 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

COPHF Stock Analysis - Frequently Asked Questions

How have COPHF shares performed this year?

Melodiol Global Health's stock was trading at $0.66 at the start of the year. Since then, COPHF stock has decreased by 82.3% and is now trading at $0.1170.
View the best growth stocks for 2024 here.

When did Melodiol Global Health's stock split?

Melodiol Global Health's stock reverse split on the morning of Wednesday, June 5th 2024. The 1-30 reverse split was announced on Wednesday, June 5th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 5th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Melodiol Global Health?

Shares of COPHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:COPHF
• CUSIP: N/A
• CIK: N/A
• Web: www.cresopharma.com
• Phone: 61-8-9389-3180
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A